233 pending office actions • 105 clients
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 19318270 | Untitled | William Marsh Rice University | EVANISKO, GEORGE ROBERT | 3792 | Non-Final OA | |
| 19317057 | Untitled | CUREVAC SE | CHEN, STACY BROWN | 1672 | Non-Final OA | |
| 18873924 | ZINC IMIDAZOLE SALICYLALDOXIME-BASED ADSORPTIVE MEMBRANES FOR REMOVAL OF METAL IONS FROM AQUEOUS SOLUTIONS | The Board Of Regents Of The University Of Oklahoma | MCCULLOUGH, ERIC J. | 1773 | Non-Final OA | Dec 11, 2024 |
| 18857661 | MAGNETICALLY STEERABLE CATHETER | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | KOLKIN, ADAM D. | 3798 | Final Rejection | Oct 17, 2024 |
| 18841126 | MOLECULAR JACKHAMMER FOR MECHANICAL DESTRUCTION OF CELLULAR STRUCTURE | William Marsh Rice University | RAMACHANDRAN, UMAMAHESWARI | 1627 | Non-Final OA | Aug 23, 2024 |
| 18833889 | NUCLEIC ACID ENCODED TRANSCRIPTION FACTOR INHIBITORS | The Schepens Eye Research Institute, Inc. | DAVIS, BRIAN J | 1614 | Non-Final OA | Jul 27, 2024 |
| 18767811 | COMPOSITIONS FOR SUPPLEMENTING PRODUCTS WITH THERAPEUTIC AGENTS AND METHOD OF USE THEREOF | Disruption Labs, Inc. | BECKHARDT, LYNDSEY MARIE | 1613 | Non-Final OA | Jul 09, 2024 |
| 18710555 | ULTRA PH-SENSITIVE MICELLES ENCAPSULATING CYTOKINES FOR TREATMENT OF CANCER | The Board Of Regents Of The University Of Texas System | CRAIGO, WILLIAM A | 1615 | Non-Final OA | May 15, 2024 |
| 18660178 | METHODS FOR THE LONG-TERM EXPANSION OF GRANULOCYTE-MACROPHAGE PROGENITORS AND APPLICATIONS THEREOF | UNIVERSITY OF SOUTHERN CALIFORNIA | WESTON, ALYSSA G | 1633 | Non-Final OA | May 09, 2024 |
| 18705061 | DRY POWDER COMPOSITIONS COMPRISING EUKARYOTIC CELLS AND METHOD OF THEIR MANUFACTURE AND USE | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | GEMBEH, SHIRLEY V | 1615 | Non-Final OA | Apr 26, 2024 |
| 18634454 | FORMATION OF STABLE SUBMICRON PEPTIDE OR PROTEIN PARTICLES BY THIN FILM FREEZING | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | BECKHARDT, LYNDSEY MARIE | 1613 | Non-Final OA | Apr 12, 2024 |
| 18698615 | COMPOSITE COATING, PREPARATION METHOD, AND DEVICE | Jiangsu Favored Nanotechnology Co., Ltd. | MILLER, BETHANY MACKENZIE | 1787 | Non-Final OA | Apr 04, 2024 |
| 18619514 | COMBINATION THERAPIES FOR THE TREATMENT OF DISEASES | Research Development Foundation | ARIANI, KADE | 1651 | Non-Final OA | Mar 28, 2024 |
| 18688749 | NOVEL LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS | CUREVAC SE | HOERNER, PAUL ELLSWORTH | 1611 | Non-Final OA | Mar 01, 2024 |
| 18432898 | METHOD FOR ANALYZING BY-PRODUCTS OF RNA IN VITRO TRANSCRIPTION | Curevac Manufacturing GmbH | ADAMS, MICHELLE | 1797 | Non-Final OA | Feb 05, 2024 |
| 18427737 | EBOLAVIRUS AND MARBURGVIRUS VACCINES | CUREVAC SE | PARKIN, JEFFREY S | 1671 | Non-Final OA | Jan 30, 2024 |
| 18425681 | CELL-TARGETED CYTOTOXIC CONSTRUCTS | Research Development Foundation | ROBINSON, HOPE A | 1652 | Non-Final OA | Jan 29, 2024 |
| 18292366 | IMPROVED DRUG PROCESSING METHODS TO INCREASE DRUG LOADING | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | SAEED, ALI S | 1616 | Non-Final OA | Jan 26, 2024 |
| 18291318 | MYOGENIC PROGENITOR CELLS FOR USE IN AN OPTIMIZED METHOD FOR THE PREVENTION AND TREATMENT OF ANAL INCONTINENCE | Innovacell GmbH | NGUYEN, NGHI V | 1653 | Non-Final OA | Jan 23, 2024 |
| 18415477 | ARTIFICIAL NUCLEIC ACID MOLECULES | CUREVAC SE | BERTOGLIO, VALARIE E | 1632 | Final Rejection | Jan 17, 2024 |
| 18413541 | METHODS AND PROBIOTIC COMPOSITIONS FOR THE TREATMENT OF METABOLIC DISEASES AND DISORDERS | Research Development Foundation | PAGUIO FRISING, MICHELLE F | 1651 | Final Rejection | Jan 16, 2024 |
| 18576938 | SYSTEMS AND METHODS FOR TROCAR SIMULATION WITH ADMITTANCE HAPTIC FEEDBACK | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | UTAMA, ROBERT J | 3715 | Non-Final OA | Jan 05, 2024 |
| 18572516 | COMPOSITE FILM APPLIED TO FLEXIBLE SUBSTRATE, PREPARATION METHOD THEREFOR, AND PRODUCT THEREOF | Jiangsu Favored Nanotechnology Co., Ltd. | NELSON, MICHAEL B | 1787 | Non-Final OA | Dec 20, 2023 |
| 18545837 | EXTRACELLULAR VESICLE-ENRICHED SECRETOME COMPOSITION DERIVED FROM INDUCED PLURIPOTENT STEM CELL DERIVED-MICROGLIA AND METHODS OF USE THEREOF | Fujifilm Holdings America Corporation | BOECKELMAN, JACOB A | 1655 | Non-Final OA | Dec 19, 2023 |
| 18541241 | HUMAN ANTIBODY SPECIFICALLY BINDING TO BINDING SITE OF HEPATOCYTE RECEPTOR OF HEPATITIS B VIRUS PRES1 ANTIGEN, AND USE THEREOF | Apitbio, Inc. | PENNINGTON, HALLIE NICOLE | 1671 | Non-Final OA | Dec 15, 2023 |
| 18540656 | NEUROPROTECTIVE LIPOSOME COMPOSITIONS AND METHODS FOR TREATMENT OF STROKE | The Board Of Regents Of The University Of Texas System | RONEY, CELESTE A | 1612 | Non-Final OA | Dec 14, 2023 |
| 18565765 | NOVEL PRODUCTION METHOD OF FLAVOCYTOCHROME B2 | Directsens GmbH | PAK, YONG D | 1652 | Non-Final OA | Nov 30, 2023 |
| 18518819 | FORMULATIONS OF DEFERASIROX AND METHODS OF MAKING THE SAME | AustinPx, LLC | ALLEY, GENEVIEVE S | 1617 | Final Rejection | Nov 24, 2023 |
| 18514277 | STORAGE SOLUTIONS FOR MAINTAINING OF AXONAL VIABILITY | David M. Jackson | BOECKELMAN, JACOB A | 1655 | Non-Final OA | Nov 20, 2023 |
| 18561900 | METHODS FOR THE EXPANSION OF HUMAN GRANULOCYTE-MACROPHAGE PROGENITORS AND APPLICATIONS THEREOF | UNIVERSITY OF SOUTHERN CALIFORNIA | CORDAS, EMILY ANN | 1632 | Non-Final OA | Nov 17, 2023 |
| 18561413 | MULTI-SPECIFIC ANTIBODY CONSTRUCTS AGAINST THE MUC1-C/EXTRACELLULAR DOMAIN (MUC1-C/ED) | DANA-FARBER CANCER INSTITUTE, INC. | CHASE, CAROL ANN | 1646 | Non-Final OA | Nov 16, 2023 |
| 18290409 | COMBINED THERAPY USING ANTI-CD300C ANTIBODY | Centricsbio, Inc. | STEPHENS, AMELIA CAROLE | 1645 | Non-Final OA | Nov 13, 2023 |
| 18558811 | PHARMACEUTICAL COMPOSITION COMPRISING CHORION EXTRACT-DERIVED EXOSOMES AS ACTIVE INGREDIENT FOR PROMOTING OSTEOGENESIS | Korea University Research And Business Foundation | WESTON, ALYSSA G | 1633 | Non-Final OA | Nov 03, 2023 |
| 18558531 | IMPROVED NUCLEIC ACID SEQUENCE FOR CELL TYPE SPECIFIC EXPRESSION | CUREVAC SE | RAHMAN, MASUDUR | 1633 | Non-Final OA | Nov 01, 2023 |
| 18557747 | COMPOSITIONS AND METHODS FOR CHIMERIC AMPLICON FORMATION | William Marsh Rice University | SALMON, KATHERINE D | 1682 | Non-Final OA | Oct 27, 2023 |
| 18557033 | ADENO-ASSOCIATED VIRAL VECTORS FOR TRANSDUCTION OF COCHLEA | The Children's Hospital of Philadelphia | SMITH, ADAM MICHAEL | 1638 | Non-Final OA | Oct 24, 2023 |
| 18556614 | ALL-IN-ONE DENDRIMER-BASED LIPID NANOPARTICLES ENABLE PRECISE HDR-MEDIATED GENE EDITING IN VIVO | The Board Of Regents Of The University Of Texas System | VANHORN, ABIGAIL LOUISE | 1636 | Non-Final OA | Oct 20, 2023 |
| 18554103 | DOPAMINERGIC PRECURSOR CELLS AND METHODS OF USE | Fujifilm Cellular Dynamics, Inc. | NGUYEN, NGHI V | 1653 | Non-Final OA | Oct 05, 2023 |
| 18553893 | ANTIMICROBIAL ELUTING AIRWAY DEVICES | The Children's Hospital of Philadelphia | CRAIGO, WILLIAM A | 1615 | Non-Final OA | Oct 04, 2023 |
| 18553840 | DONOR-ACCEPTOR CONJUGATED OLIGOELECTROLYTES FOR CELL LABELLING AND METHODS THEREOF | National University Of Singapore | CHONG, YONG SOO | 1623 | Non-Final OA | Oct 03, 2023 |
| 18553531 | SYRINGES CONTAINING PHARMACEUTICAL COMPOSITIONS COMPRISING RNA | CUREVAC SE | RYAN, DOUGLAS CHARLES | 1635 | Non-Final OA | Sep 29, 2023 |
| 18478261 | COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL OR MITOCHONDRIAL DISEASES | Musc Foundation For Research Development | SZNAIDMAN, MARCOS L | 1628 | Non-Final OA | Sep 29, 2023 |
| 18552262 | NUCLEOTIDE EDITING TO REFRAME DMD TRANSCRIPTS BY BASE EDITING AND PRIME EDITING | The Board Of Regents Of The University Of Texas System | CORDAS, EMILY ANN | 1632 | Non-Final OA | Sep 25, 2023 |
| 18551444 | ANHYDROUS POLYMORPHS OF ANDROGEN RECEPTOR ANTAGONIST, PREPARATION METHOD THEREFOR, AND USE THEREOF | Suzhou Kintor Pharmaceuticals, Inc. | MOU, LIYUAN | 1628 | Non-Final OA | Sep 20, 2023 |
| 18282689 | SARS-COV-2 SUBUNIT VACCINE | VIRAVAXX AG | PENNINGTON, HALLIE NICOLE | 1671 | Non-Final OA | Sep 18, 2023 |
| 18550194 | SARS-COV-2 NEUTRALIZING ANTIBODIES AND USES THEREOF | Jimmy Dale Gollihar | XIAO, YAN | 1642 | Non-Final OA | Sep 12, 2023 |
| 18465547 | HUMAN APPLICATION OF ENGINEERED CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | BURKHART, MICHAEL D | 1638 | Non-Final OA | Sep 12, 2023 |
| 18465333 | COMPOSITONS AND METHODS FOR USE OF KALIUM CHANNEL RHODOPSINS | BAYLOR COLLEGE OF MEDICINE | POPA, ILEANA | 1633 | Non-Final OA | Sep 12, 2023 |
| 18549844 | GENERATION OF HUMAN PEANUT ALLERGEN-SPECIFIC IGE MONOCLONAL ANTIBODIES FOR DIAGNOSTIC AND THERAPEUTIC USE | VANDERBILT UNIVERSITY | SANG, HONG | 1646 | Non-Final OA | Sep 08, 2023 |
| 18549645 | DRY POWDER FORMULATIONS OF NUCLEIC ACID LIPID NANOPARTICLES | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | SHOMER, ISAAC | 1612 | Final Rejection | Sep 08, 2023 |
| 18463282 | USE OF SDHA AS A PROGNOSTIC MARKER AND THERAPEUTIC TARGET IN UVEAL MELANOMA | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | SALMON, KATHERINE D | 1682 | Final Rejection | Sep 07, 2023 |
| 18548343 | COMPOSITE COATING, PREPARATION METHOD, AND DEVICE | Jiangsu Favored Nanotechnology Co., Ltd. | VAN SELL, NATHAN L | 1783 | Non-Final OA | Aug 30, 2023 |
| 18548413 | COLLAGENOUS EXTRACTS FOR USE AS A MEDICAMENT | Jellagen Ltd. | KATAKAM, SUDHAKAR | 1658 | Non-Final OA | Aug 30, 2023 |
| 18456061 | ANTIMICROBIAL CATHETERS | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | YOON, TAE H | 1762 | Non-Final OA | Aug 25, 2023 |
| 18547687 | METHODS FOR POLYPEPTIDE PROCESSING AND ANALYSIS | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | XU, XIAOYUN | 1797 | Non-Final OA | Aug 23, 2023 |
| 18547408 | MAGNETIC SHEAR BIOREACTOR APPARATUS AND METHODS | The Board Of Regents Of The University Of Texas System | BOWERS, NATHAN ANDREW | 1799 | Non-Final OA | Aug 22, 2023 |
| 18449100 | GENERATION OF INDUCED PLURIPOTENT STEM CELLS FROM SMALL VOLUMES OF PERIPHERAL BLOOD | Fujifilm Cellular Dynamics, Inc. | GRABER, JAMES J | 1631 | Non-Final OA | Aug 14, 2023 |
| 18449422 | SURFACE-BASED DETECTION OF NUCLEIC ACID IN A CONVECTION FLOW FLUIDIC DEVICE | William Marsh Rice University | SISSON, BRADLEY L | 1682 | Final Rejection | Aug 14, 2023 |
| 18449675 | LIBRARY OF PH RESPONSIVE POLYMERS AND NANOPROBES THEREOF | The Board Of Regents Of The University Of Texas System | LAZARO, DOMINIC | 1611 | Non-Final OA | Aug 14, 2023 |
| 18546141 | LOW INTENSITY ULTRASOUND COMBINATION CANCER THERAPIES | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | MACFARLANE, STACEY NEE | 1675 | Non-Final OA | Aug 11, 2023 |
| 18364809 | PCR DETECTION OF SMALL FRAGMENTS OF A KNOWN NUCLEIC ACID TARGET | VANDERBILT UNIVERSITY | HORLICK, KENNETH R | 1681 | Non-Final OA | Aug 03, 2023 |
| 18264143 | COMPOSITIONS AND METHODS FOR TREATMENT OF HIDRADENITIS SUPPURATIVA | Suzhou Kintor Pharmaceuticals, Inc. | HUI, SAN MING R | 1627 | Non-Final OA | Aug 03, 2023 |
| 18363255 | ENZYMATICALLY INACTIVE GRANZYME A AND USES THEREFORE | Saint Louis University | KANE, TREVOR LOGAN | 1657 | Non-Final OA | Aug 01, 2023 |
| 18274845 | HUMANIZED ANTIBODY AGAINST TNFR2 AND USE THEREOF | (Jiangsu Simcere Pharmaceutical Co., Ltd.) | LEE, YIE CHIA | 1642 | Non-Final OA | Jul 28, 2023 |
| 18263191 | USE OF COMPOSITION CONTAINING CILOSTAZOL IN CEREBROVASCULAR DISEASES | Neurodawn Pharmaceutical Co., Ltd. | ROZOF, TIMOTHY R | 1625 | Non-Final OA | Jul 27, 2023 |
| 18261983 | BONE-SPECIFIC DELIVERY OF POLYPEPTIDES | BAYLOR COLLEGE OF MEDICINE | DUNN, LINDSAY MICHELLE | 1644 | Non-Final OA | Jul 18, 2023 |
| 18272449 | DEVICE AND METHOD FOR THE SECURE PROCESSING OF DATA | Real-Cis GmbH | SWEARINGEN, JEFFREY R | 2445 | Final Rejection | Jul 14, 2023 |
| 18271991 | APPLICATION OF CILOSTAZOL-CONTAINING COMPOSITION IN PREPARING DRUG FOR TREATING CEREBROVASCULAR DISEASE | Neurodawn Pharmaceutical Co., Ltd. | SCHMITT, MICHAEL J | 1629 | Non-Final OA | Jul 12, 2023 |
| 18260891 | CROSS-REACTIVE ANTIBODIES RECOGNIZING THE CORONAVIRUS SPIKE S2 DOMAIN | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | MELCHIOR, JAMES RYLAND | 1644 | Non-Final OA | Jul 10, 2023 |
| 18271294 | DRIED CELL SECRETOME-BASED THERAPEUTIC AGENT FOR OSTEOARTHRITIS TREATMENT | Seoul National University R&Db Foundation | RAHMAN, MASUDUR | 1633 | Non-Final OA | Jul 07, 2023 |
| 18348207 | QUATERNARY AMMONIUM COMPOUNDS AS ANTIMICROBIALS | The Board Of Regents Of The University Of Oklahoma | DEKARSKE, MADELINE MCGUIRE | 1622 | Non-Final OA | Jul 06, 2023 |
| 18271131 | SPRAY-TYPE HYDROGEL | Seoul National University R&Db Foundation | GULLEDGE, BRIAN M | 1699 | Non-Final OA | Jul 06, 2023 |
| 18270915 | METHOD FOR DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDER ON BASIS OF ACTIVITY REGULATION MECHANISM OF DORMANT NEURAL STEM CELL | Dongguk University Industry-Academic Cooperation Foundation | GIBBS, TERRA C | 1635 | Non-Final OA | Jul 05, 2023 |
| 18270806 | NOVEL ANTIMICROBIAL PEPTIDE WITH EXCELLENT MICROBIAL CYTOPLASM ELUTION EFFECT | Cellicon Lab Inc. | VARADARAJ, ARCHANA | 1658 | Non-Final OA | Jul 03, 2023 |
| 18270818 | NOVEL SKIN-PERMEABLE PEPTIDE, COMPOSITION INCLUDING THE SAME FOR SKIN AND MUCOUS MEMBRANE, AND USE THEREOF | Cellicon Lab Inc. | CHANDRAKUMAR, NIZAL S | 1625 | Final Rejection | Jul 03, 2023 |
| 18270476 | ORAL SOLID FORMULATION FOR COLON CLEANSING | Taejoon Pharmaceutical Co., Ltd. | ATKINSON, JOSHUA ALEXANDER | 1612 | Final Rejection | Jun 29, 2023 |
| 18270028 | 2-PYRIDONE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL APPLICATION THEREOF | Shanghai Kunheng Pharma-Tech Co., Ltd. | HEITMEIER, KENDALL NICOLE | 1621 | Non-Final OA | Jun 28, 2023 |
| 18259640 | AN AGR2Xcd3 BISPECIFIC ENGAGER FOR THE TREATMENT OF CANCER | Musc Foundation For Research Development | CHHAY, BONIRATH | 1645 | Non-Final OA | Jun 28, 2023 |
| 18259246 | FLUORESCENT DYES | Exopharm Limited | SHTERENGARTS, SAMANTHA L | 1623 | Non-Final OA | Jun 23, 2023 |
| 18268752 | METHODS AND COMPOSITIONS COMPRISING TUMOR SUPPRESSOR GENE THERAPY FOR THE INHIBITION OF PATHOGENS | Multivir Inc. | WESTON, ALYSSA G | 1633 | Non-Final OA | Jun 21, 2023 |
| 18335990 | LIPOCATIONIC DENDRIMERS AND USES THEREOF | The Board Of Regents Of The University Of Texas System | VANHORN, ABIGAIL LOUISE | 1636 | Non-Final OA | Jun 15, 2023 |
| 18332571 | ENGINEERED FCRIIB SELECTIVE IGG1 FC VARIANTS AND USES THEREOF | Research Development Foundation | BUTTICE, AUDREY L | 1647 | Non-Final OA | Jun 09, 2023 |
| 18332603 | METHODS OF TREATING AND PREVENTING ENDOTHELIAL DYSFUNCTION USING BARDOXOLONE METHYL OR ANALOGS THEREOF | Reata Pharmaceuticals Holdings, LLC | MOU, LIYUAN | 1628 | Non-Final OA | Jun 09, 2023 |
| 18256545 | METHODS OF ADMINISTERING SYNTHETIC TRITERPENOIDS | Reata Pharmaceuticals Holdings, LLC | SHIAO, REI TSANG | 1691 | Final Rejection | Jun 08, 2023 |
| 18265780 | EXHAUST GAS FILTERING APPARATUS AND COATING EQUIPMENT | Jiangsu Favored Nanotechnology Co., Ltd. | HAQ, WASIQUL | 1717 | Non-Final OA | Jun 07, 2023 |
| 18329381 | 6-THIO-2'-DEOXYGUANOSINE (6-THIO-DG) RESULTS IN TELOMERASE DEPENDENT TELOMERE DYSFUNCTION AND CELL DEATH IN VARIOUS MODELS OF THERAPY-RESISTANT CANCER CELLS | The Wistar Institute | CREWS, JARET JAMES | 1691 | Non-Final OA | Jun 05, 2023 |
| 18324828 | L-DNA ENCRYPTED TRACERS | VANDERBILT UNIVERSITY | CASH, KAILEY ELIZABETH | 1683 | Non-Final OA | May 26, 2023 |
| 18254595 | DEVICE FOR PREPARING A DNA PRODUCT BY MEANS OF CAPILLARY POLYMERASE CHAIN REACTION | Tesla Automation GmbH | CROW, ROBERT THOMAS | 1683 | Non-Final OA | May 25, 2023 |
| 18038181 | DIRECT LYSIS APPARATUS AND METHODS FOR MOLECULAR DIAGNOSTICS | Nuclein, LLC | NGUYEN, HENRY H | 1758 | Non-Final OA | May 22, 2023 |
| 18253755 | USE OF MICROVIRIN IN THE IDENTIFICATION OF MYCOBACTERIUM TUBERCULOSIS MANNOSE-CAPPED LIPOARABINOMANNAN | UNIVERSITY OF CAPE TOWN | DEVI, SARVAMANGALA | 1645 | Non-Final OA | May 19, 2023 |
| 18253687 | USE OF MATURE MITOCHONDRIAL TRANSCRIPTION FACTOR A (TFAM) FOR DIAGNOSING ORGAN DYSFUNCTIONS | Universitätsklinikum Knappschaftskrankenhaus Bochum GmbH | VANN-OJUEKAIYE, KENDRA RAYCHELL | 1682 | Non-Final OA | May 19, 2023 |
| 18320187 | ARTIFICIAL NUCLEIC ACID MOLECULES | CUREVAC SE | GRAY, JESSICA | 1682 | Non-Final OA | May 18, 2023 |
| 18037282 | APPARATUS AND METHODS FOR MOLECULAR DIAGNOSTICS | Nuclein, LLC | KRCHA, MATTHEW D | 1796 | Non-Final OA | May 16, 2023 |
| 18036488 | SALICYLIC ACID-INDUCIBLE GENE EXPRESSION COMPOSITIONS AND SYSTEMS FOR CELLS | UNIVERSITY OF HOUSTON SYSTEM | LEONARD, ARTHUR S | 1631 | Non-Final OA | May 11, 2023 |
| 18315781 | METHOD FOR PRODUCING RNA MOLECULE COMPOSITIONS | CUREVAC SE | ARIETI, RUTH SOPHIA | 1635 | Non-Final OA | May 11, 2023 |
| 18252185 | METHOD FOR PREDICTING RESPONSIVENESS TO PLK1 INHIBITION | National University Of Singapore | BAUSCH, SARAE L | 1699 | Non-Final OA | May 08, 2023 |
| 18250645 | MUTANT PROTEASES AND USES THEREOF | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | MARTIN, RACHEL E | 1657 | Non-Final OA | Apr 26, 2023 |
| 18250532 | DIRECTIONAL AND SCALABLE ELECTRODE ARRAY | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | PORTER, JR, GARY A | 3796 | Final Rejection | Apr 25, 2023 |
| 18306038 | ICOS TARGETING FOR NEUROPATHIC PAIN RELIEF | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | TRAN HO, LAM THUY VI | 1647 | Non-Final OA | Apr 24, 2023 |
| 18249647 | ORAL CANNABINOID FORMULATION COMPRISING MEDIUM CHAIN TRIGLYCERIDES AND TOCOPHERYL PHOSPHATES | Avecho Biotechnology Limited | KUCHARCZK, JED A | 1623 | Non-Final OA | Apr 19, 2023 |
| 18031793 | USE OF MICROORGANISMS AND CALCIUM FOR IMPROVED PLANT HELATH AND/OR RESILIENCE AGAINST PLANT PATHOGENS | Valibiotics GmbH | UNDERDAHL, THANE E | 1699 | Final Rejection | Apr 13, 2023 |
| 18028637 | CYCLIC ISOTHIOUREA DERIVATIVES AS CXCR4 MODULATORS | Centre National De La Recherche Scientifique | MCDOWELL, BRIAN E | 1624 | Non-Final OA | Mar 27, 2023 |
| 18026696 | THERAPEUTIC AGENTS AND USES THEREOF | The Board Of Regents Of The University Of Texas System | HOWARD, ZACHARY C | 1674 | Non-Final OA | Mar 16, 2023 |
| 18183082 | RNA ENCODING A TUMOR ANTIGEN | CUREVAC SE | SHIN, DANA H | 1635 | Non-Final OA | Mar 13, 2023 |
| 18044877 | PHARMACEUTICAL COMPOSITIONS OF NICLOSAMIDE AND A PROTEIN | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | BASQUILL, SEAN M | 1614 | Final Rejection | Mar 10, 2023 |
| 18044703 | ANTIBODIES SPECIFICALLY RECOGNIZING INTERLEUKIN-4 RECEPTOR ALPHA AND USES THEREOF | Staidson (Beijing) Biopharmaceutical Co., Ltd. | LANDSMAN, ROBERT S | 1647 | Non-Final OA | Mar 09, 2023 |
| 18044668 | BISPECIFIC FUSION POLYPEPTIDE COMPOUND | Shaanxi Micot Pharmaceutical Technology Co., Ltd. | STEELE, AMBER D | 1658 | Non-Final OA | Mar 09, 2023 |
| 18180377 | METHODS FOR OBTAINING MUSCLE DERIVED CELLS | Innovacell AG | JOHNSON, KARA D | 1632 | Non-Final OA | Mar 08, 2023 |
| 18178368 | DIRECT METHOD OF SYNTHESIS OF ZNO NWS/SWCNTS AND ZNO NWS/GRAPHENE HETEROSTRUCTURES | Saint Louis University | WALTERS JR, ROBERT S | 1717 | Final Rejection | Mar 03, 2023 |
| 18043577 | MANUFACTURING DEVICE FOR A PHARMACEUTICAL PRODUCT | Tesla Automation GmbH | SHI, TINGCHEN | 1796 | Non-Final OA | Feb 28, 2023 |
| 18043317 | MULTIVALENT NUCLEIC ACID BASED CORONAVIRUS VACCINES | CUREVAC SE | BUCKMASTER, MARLENE VRENI | 1672 | Non-Final OA | Feb 27, 2023 |
| 18173246 | ELECTROTHERMAL FLOW-ENHANCED ELECTROCHEMICAL MAGNETO-IMMUNOSENSOR | William Marsh Rice University | EVANS, CHRISTOPHER RYAN | 1677 | Non-Final OA | Feb 23, 2023 |
| 18041811 | NANODRUGS FOR TARGETED DRUG DELIVERY AND USE THEREOF | UNIVERSITY OF CONNECTICUT | RONEY, CELESTE A | 1612 | Final Rejection | Feb 16, 2023 |
| 18041470 | TEXAPHYRIN DERIVATIVES FOR MANGANESE CHEMOTHERAPY, PHOTOACOUSTIC IMAGING, AND PHOTOTHERMAL THERAPY | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | JONES, DAMERON LEVEST | 1618 | Non-Final OA | Feb 13, 2023 |
| 18041475 | METHOD OF PRODUCING PHARMACEUTICAL COCRYSTALS FOR ADDITIVE MANUFACTURING | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | BAUER, NICOLA MARIA | 1621 | Non-Final OA | Feb 13, 2023 |
| 18041226 | NOVEL MEANS TO PREDICT AND MANIPULATE NMDA RECEPTOR-MEDIATED TOXICITY | Fundamental Pharma GmbH | GURLEY, JAMI MICHELLE | 1647 | Non-Final OA | Feb 10, 2023 |
| 18162399 | MODIFICATION OF PLANT GENE EXPRESSION TO EFFECT INCREASED SEED SIZE AND YIELD | Saint Louis University | DELEO, VICTORIA LYNN | 1662 | Final Rejection | Jan 31, 2023 |
| 18019045 | METHODS FOR SCREENING EMBRYOS | Unknown | HANEY, AMANDA MARIE | 1682 | Non-Final OA | Jan 31, 2023 |
| 18007468 | NUCLEIC ACID ENCODED ANTIBODY MIXTURES | CUREVAC SE | HECK, BRYAN WILLIAM | 1643 | Non-Final OA | Jan 30, 2023 |
| 18018518 | BROAD-SPECTRUM ANTIVIRAL DRUG FOR ENTEROVIRUS, AND APPLICATION | Wuhan Institute Of Virology, Chinese Academy Of Sciences | COFFA, SERGIO | 1658 | Non-Final OA | Jan 27, 2023 |
| 18017669 | USE OF PERLECAN AND FRAGMENTS THEREOF TO REDUCE THE RISK OF DEATH IN STROKE PATIENTS | Stream Biomedical, Inc. | STEELE, AMBER D | 1658 | Non-Final OA | Jan 23, 2023 |
| 18005562 | ANTIBODIES AGAINST THE MUC1-C/EXTRACELLULAR DOMAIN (MUC1-C/ECD) | Xyone Therapeutics, Inc. | QIAN, CELINE X | 1637 | Non-Final OA | Jan 13, 2023 |
| 18014746 | SUPER HYDROPHOBIC FILM LAYER, PREPARATION METHOD THEREOF,AND PRODUCT THEREOF | Jiangsu Favored Nanotechnology Co., Ltd. | EMPIE, NATHAN H | 1712 | Non-Final OA | Jan 06, 2023 |
| 18147365 | RNA ENCODING AN ANTIBODY | CUREVAC SE | BURKHART, MICHAEL D | 1638 | Non-Final OA | Dec 28, 2022 |
| 18003412 | AMPLICON COMPREHENSIVE ENRICHMENT | William Marsh Rice University | BERTAGNA, ANGELA MARIE | 1681 | Non-Final OA | Dec 27, 2022 |
| 18146038 | LATERAL FLOW DETECTION DEVICE FOR ACUTE AORTIC SYNDROME | Pericard Check GmbH | FRITCHMAN, REBECCA M | 1758 | Final Rejection | Dec 23, 2022 |
| 18011073 | IMPROVED THROMBIN INHIBITORS FOR TREATMENT OF THROMBOEMBOLIC CONDITIONS | The Heart Research Institute Ltd. | DESAI, ANAND U | 1655 | Non-Final OA | Dec 16, 2022 |
| 18001411 | 3D LASER SINTERING PROCESSES FOR IMPROVED DRUG DELIVERY | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | BROWE, DAVID | 1617 | Final Rejection | Dec 09, 2022 |
| 18062918 | METHODS AND COMPOSITIONS FOR NUCLEIC ACID ANALYSIS | Luminex Corporation | GRAY, JESSICA | 1682 | Non-Final OA | Dec 07, 2022 |
| 18060183 | ELIMINATION OF PROLIFERATING CELLS FROM STEM CELL-DERIVED GRAFTS | Research Development Foundation | NOBLE, MARCIA STEPHENS | 1632 | Non-Final OA | Nov 30, 2022 |
| 18060134 | METHODS AND PROBIOTIC COMPOSITIONS FOR THE TREATMENT OF BONE DISORDERS | Research Development Foundation | FAN, LYNN Y | 1759 | Final Rejection | Nov 30, 2022 |
| 18000183 | Treatment Of Homocystinuria And Hyperhomocysteinemia Using Cystathionine-Gamma-Lyase | The Board Of Regents Of The University Of Texas System | CURRENS, GRANT CARSON | 1651 | Final Rejection | Nov 29, 2022 |
| 18000071 | RETINAL PIGMENTED EPITHELIUM AND PHOTORECEPTOR DUAL CELL AGGREGATES AND METHODS OF USE THEREOF | Fujifilm Cellular Dynamics, Inc. | PAPCIAK, SHARON M | 1657 | Non-Final OA | Nov 28, 2022 |
| 17999735 | ADAPTER MOLECULES TO RE-DIRECT CAR T CELLS TO AN ANTIGEN OF INTEREST | UNIVERSITY OF ZURICH | BENAVIDES, JENNIFER ANN | 1675 | Non-Final OA | Nov 23, 2022 |
| 17999400 | MAXI-K POTASSIUM CHANNEL OPENERS FOR THE TREATMENT OF FRAGILE X ASSOCIATED DISORDERS | Servier Pharmaceuticals LLC | OLSON, ANDREA STEFFEL | 1693 | Non-Final OA | Nov 20, 2022 |
| 18056970 | METHODS, SYSTEMS AND KITS FOR POLYPEPTIDE PROCESSING AND ANALYSIS | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | BOESEN, CHRISTIAN C | 1684 | Non-Final OA | Nov 18, 2022 |
| 17999299 | GRANULES FOR 3D PRINTING TECHNOLOGY | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | SZNAIDMAN, MARCOS L | 1628 | Final Rejection | Nov 18, 2022 |
| 18055793 | POISSON SIGNAL RECOVERY FROM MULTIPLE MEASUREMENTS | William Marsh Rice University | FONSECA LOPEZ, FRANCINI ALVARENGA | 1685 | Non-Final OA | Nov 15, 2022 |
| 18055822 | METHODS AND COMPOSITIONS FOR DETERMINING, AND FOR MINIMIZING, THE LIKELIHOOD OF DEVELOPMENT OF ALLERGY IN INFANTS | Murdoch Children'S Research Institute | WILDER, CYNTHIA B | 1681 | Non-Final OA | Nov 15, 2022 |
| 17998194 | PROTEINS AND NUCLEIC ACIDS FOR EHRLICHIA DIAGNOSIS AND VACCINATION | Research Development Foundation | OGUNBIYI, OLUWATOSIN A | 1645 | Non-Final OA | Nov 08, 2022 |
| 18052476 | SERINE PROTEASE MOLECULES AND THERAPIES | Research Development Foundation | LI, RUIXIANG | 1674 | Final Rejection | Nov 03, 2022 |
| 17997696 | QUANTITATIVE BLOCKER DISPLACEMENT AMPLIFICATION (QBDA) SEQUENCING FOR CALIBRATION-FREE AND MULTIPLEXED VARIANT ALLELE FREQUENCY QUANTITATION | William Marsh Rice University | PRIEST, AARON A | 1681 | Non-Final OA | Nov 01, 2022 |
| 17997453 | ALBUMIN DRUG CONJUGATES AND USE THEREOF FOR THE TREATMENT OF CANCER | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | LEE, JAE W | 1656 | Non-Final OA | Oct 28, 2022 |
| 17920313 | METHODS FOR GENERATION OF MOUSE AND HUMAN URETERIC BUD ORGANOIDS AND COLLECTING DUCT ORGANOIDS | UNIVERSITY OF SOUTHERN CALIFORNIA | SHIBUYA, MARK LANCE | 1631 | Non-Final OA | Oct 20, 2022 |
| 17996618 | LIPID NANOPARTICLE (LNP) DELIVERY SYSTEMS AND USES THEREOF | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | LIPPERT, JOHN WILLIAM | 1615 | Non-Final OA | Oct 19, 2022 |
| 17917545 | JELLYFISH COLLAGEN USE | Jellagen Limited | MELLER, MICHAEL V | 1655 | Final Rejection | Oct 06, 2022 |
| 17916998 | DECELLULARIZED MENISCAL CARTILAGE AND USES THEROF | The Children's Hospital of Philadelphia | MITCHELL, EDWIN COLEMAN | 1619 | Final Rejection | Oct 04, 2022 |
| 17938003 | KRATOM OPIOID DERIVATIVES FOR THE TREATMENT OF ALCOHOL USE DISORDER | The Trustees of Columbia University in the City of New York | MOORE, SUSANNA | 1624 | Non-Final OA | Oct 04, 2022 |
| 17995214 | CD5L-BINDING ANTIBODIES AND USES FOR THE SAME | The Board Of Regents Of The University Of Texas System | DARPOLOR, JOSEPHINE KEBBEH | 1642 | Non-Final OA | Sep 30, 2022 |
| 17907386 | FOOD COLOURING AGENTS | V2Food Pdy Ltd. | DIVIESTI, KARLA ISOBEL | 1792 | Non-Final OA | Sep 26, 2022 |
| 17907375 | MONOCLONAL ANTIBODIES TARGETING HSP70 AND THERAPEUTIC USES THEREOF | Asylia Therapeutics | LEE, YIE CHIA | 1642 | Non-Final OA | Sep 26, 2022 |
| 17641048 | METHOD FOR SEQUENCING RNA OLIGONUCLEOTIDES | Cemm - Forschungszentrum Für Molekulare Medizin GmbH | CASH, KAILEY ELIZABETH | 1683 | Non-Final OA | Sep 08, 2022 |
| 17905088 | DIBORIDE MICROPATTERNED SURFACES FOR CELL CULTURE | UNIVERSITY OF HOUSTON SYSTEM | TICHY, JENNIFER M.H. | 1653 | Non-Final OA | Aug 26, 2022 |
| 17905143 | TREATMENT OF CARM1-OVEREXPRESSING AND/OR ARID1A MUTANT CANCERS WITH IRE-1/XBP-1 INHIBITORS | The Wistar Institute | SIMMONS, CHRIS E | 1622 | Non-Final OA | Aug 26, 2022 |
| 17822332 | TARGETED MEASURE OF TRANSCRIPTIONAL ACTIVITY RELATED TO HORMONE RECEPTORS | Yale University | JOHANNSEN, DIANA B | 1682 | Non-Final OA | Aug 25, 2022 |
| 17820277 | DIGITAL AMPLIFICATION ASSAY ANALYSIS METHOD | Luminex Corporation | KIM, YOUNG J | 1681 | Final Rejection | Aug 17, 2022 |
| 17819268 | DRY LIPOSOME FORMULATIONS AND RELATED METHODS THEREOF | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | HOERNER, PAUL ELLSWORTH | 1611 | Final Rejection | Aug 11, 2022 |
| 17819286 | DRY LIPOSOME ADJUVANT-CONTAINING VACCINES AND RELATED METHODS THEREOF | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | MACH, ANDRE | 1615 | Final Rejection | Aug 11, 2022 |
| 17819259 | DRY POWDER COMPOSITIONS OF OIL-IN-WATER (O/W) EMULSION ADJUVANTED VACCINES | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | LI, BAO Q | 1671 | Final Rejection | Aug 11, 2022 |
| 17929013 | METHODS FOR RAPID CLONING AND EXPRESSION OF HLA CLASS I CELLS | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | QIAN, CELINE X | 1637 | Non-Final OA | Aug 10, 2022 |
| 17759824 | USE OF EGFR/HER2 TYROSINE KINASE INHIBITORS AND/OR HER2/HER3 ANTIBODIES FOR THE TREATMENT OF CANCERS WITH NRG1 FUSIONS | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | SUNSHINE, HANNAH LOUISE | 1647 | Final Rejection | Jul 29, 2022 |
| 17815711 | GENOME ENGINEERING THE HUMAN IMMUNOGLOBULIN LOCUS TO EXPRESS RECOMBINANT BINDING DOMAIN MOLECULES | UNIVERSITY OF SOUTHERN CALIFORNIA | KONOPKA, CATHERINE ANNE | 1635 | Non-Final OA | Jul 28, 2022 |
| 17759542 | NUTRACEUTICAL EXTRACTS OF HIPPOPHAE RHAMNOIDES AND TERMINALIA CHEBULA AND USES THEREOF | Biomics, LLC | CAIN, JENNIFER LYNN | 1655 | Non-Final OA | Jul 27, 2022 |
| 17759479 | HUMAN ANTI-DENGUE ANTIBODIES AND METHODS OF USE THEREFOR | The Regebts Of The University Of California A California | QIAN, CELINE X | 1637 | Non-Final OA | Jul 26, 2022 |
| 17794920 | COMPOSITIONS AND METHODS TO TREAT NEUROLOGICAL DISEASES | UNIVERSITY OF SOUTHERN CALIFORNIA | GIBBS, TERRA C | 1635 | Final Rejection | Jul 22, 2022 |
| 17862090 | Systems and Methods for Recovering Lithium from Brines Field | Energy Exploration Technologies, Inc. | MENDEZ, ZULMARIAM | 1794 | Final Rejection | Jul 11, 2022 |
| 17757701 | SYNTHETIC TRITERPENOIDS WITH NITROGEN-BASED SUBSTITUENTS AT C-17 AND METHODS OF USE THEREOF | Reata Pharmaceuticals, Inc. | CHAO, ALLEN | 1622 | Non-Final OA | Jun 17, 2022 |
| 17757550 | NOVEL G-CSF MIMICS AND THEIR APPLICATIONS | EBERHARD KARLS UNIVERSITÄT TÜBINGEN | MARTINEZ, TARA L | 1654 | Non-Final OA | Jun 16, 2022 |
| 17833346 | METHOD FOR PRODUCING COLLAGEN HYDROGELS | Jellagen Pty Ltd. | FOX, ALLISON M | 1633 | Non-Final OA | Jun 06, 2022 |
| 17782314 | A BIOMARKER AND USES THEREFOR | Perron Institute For Neurological And Translational Science Limited | KAPUSHOC, STEPHEN THOMAS | 1683 | Non-Final OA | Jun 03, 2022 |
| 17782169 | COATING EQUIPMENT | Jiangsu Favored Nanotechnology Co., Ltd. | FORD, NATHAN K | 1716 | Non-Final OA | Jun 03, 2022 |
| 17782147 | COMBINATION THERAPIES FOR THE TREATMENT OF CANCER | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | JONES, DAMERON LEVEST | 1618 | Non-Final OA | Jun 02, 2022 |
| 17778927 | NOVEL METHOD FOR POOLED INTRON TAGGING FOR REAL TIME DRUG SCREENING | Cemm - Forschungszentrum Für Molekulare Medizin GmbH | CHOWDHURY, IQBAL HOSSAIN | 1656 | Non-Final OA | May 23, 2022 |
| 17746569 | ANTI-CD300C MONOCLONAL ANTIBODY AND BIOMARKER THEREOF FOR PREVENTING OR TREATING CANCER | Centricsbio, Inc. | BERHANE, SELAM | 1675 | Final Rejection | May 17, 2022 |
| 17774848 | METHOD FOR PRODUCING CYTOTOXIC EFFECTOR MEMORY T-CELLS FOR CAR T-CELL TREATMENT OF CANCER | BAYLOR COLLEGE OF MEDICINE | HILL, KEVIN KAI | 1638 | Final Rejection | May 05, 2022 |
| 17774782 | TREATMENT OF GASTROINTESTINAL DISEASE | The Queensland Institute of Medical Research | MCCOLLUM, ANDREA K | 1674 | Final Rejection | May 05, 2022 |
| 17774136 | PET IMAGING OF CANCEROUS CELLS USING 18F-FLUOROACETATE | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | SCHLIENTZ, LEAH H | 1618 | Final Rejection | May 03, 2022 |
| 17773682 | TARGETING NONSENSE-MEDIATED DECAY TO ACTIVATE P53 PATHWAY FOR THE TREATMENT OF CANCER | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | ZARA, JANE J | 1637 | Non-Final OA | May 02, 2022 |
| 17770601 | BIOLOGICAL SAMPLE COLLECTION PAD | ZYMO RESEARCH CORPORATION | MCCORMACK, ERIN KATHLEEN | 3791 | Final Rejection | Apr 20, 2022 |
| 17769323 | COMPOUNDS FOR TARGETED DEGRADATION OF CARRIER PROTEINS AND USES THEREOF | Cemm - Forschungszentrum Für Molekulare Medizin GmbH | RAO, PADMAJA S | 1627 | Non-Final OA | Apr 14, 2022 |
| 17767690 | FEEDER-BASED AND FEEDER-FREE STEM CELL CULTURE SYSTEMS FOR STRATIFIED EPITHELIAL STEM CELLS, AND USES RELATED THERETO | UNIVERSITY OF HOUSTON SYSTEM | LEAVITT, MARIA GOMEZ | 1634 | Final Rejection | Apr 08, 2022 |
| 17698906 | COMPOSITIONS FOR DELIVERY OF DRUG COMBINATIONS TO TREAT LUNG DISEASE | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | KWON, JOHN SEUNGJAI | 1615 | Non-Final OA | Mar 18, 2022 |
| 17693062 | METHODS TO PREPARE DRY POWDERS USING SUSPENSION BASED THIN FILM FREEZING | Tff Pharmaceuticals, Inc. | GOTFREDSON, GAREN | 1619 | Final Rejection | Mar 11, 2022 |
| 17634958 | RNA COMBINATIONS AND COMPOSITIONS WITH DECREASED IMMUNOSTIMULATORY PROPERTIES | Curevac AG | SHIN, DANA H | 1635 | Non-Final OA | Feb 11, 2022 |
| 17589879 | METHOD FOR PRODUCING RNA | Curevac Real Estate GmbH | YU, TIAN NMN | 1681 | Non-Final OA | Jan 31, 2022 |
| 17631433 | ANTIBODIES TO CANDIDA AND USES THEREOF | Stadius Biopharma, LLC | MIDDLETON, DANAYA L | 1674 | Non-Final OA | Jan 28, 2022 |
| 17576597 | DENDRITIC CELL IMMUNOTHERAPY | BAYLOR COLLEGE OF MEDICINE | JUEDES, AMY E | 1644 | Final Rejection | Jan 14, 2022 |
| 17576583 | ARTIFICIAL NUCLEIC ACID MOLECULES | Curevac AG | LEITH, NANCY J | 1636 | Non-Final OA | Jan 14, 2022 |
| 17275412 | NET STABILIZATION AS A THERAPY FOR SEPSIS | The Children's Hospital of Philadelphia | GURLEY, JAMI MICHELLE | 1647 | Final Rejection | Jan 05, 2022 |
| 17567868 | METHODS FOR PREDICTING KINASE INHIBITOR RESISTANCE | Research Development Foundation | DESAI, ANAND U | 1655 | Final Rejection | Jan 03, 2022 |
| 17620605 | METHODS FOR DUPLEX SEQUENCING OF CELL-FREE DNA AND APPLICATIONS THEREOF | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | PARISI, JESSICA DANIELLE | 1684 | Non-Final OA | Dec 17, 2021 |
| 17620047 | ROTAVIRUS MRNA VACCINE | Curevac AG | GRABER, JAMES J | 1631 | Final Rejection | Dec 16, 2021 |
| 17596622 | USE OF SRRD IN THE INHIBITION OF PROTEIN AGGREGATION | The Children's Hospital of Philadelphia | WANG, CHANG YU | 1675 | Final Rejection | Dec 14, 2021 |
| 17619096 | METHODS FOR THE PRODUCTION OF MULTIPLE LINEAGES FROM INDUCED PLURIPOTENT STEM CELLS USING CHARGED SURFACES | Fujifilm Holdings America Corporation | BEHARRY, ZANNA MARIA | 1632 | Non-Final OA | Dec 14, 2021 |
| 17548467 | SYSTEMS AND METHODS FOR LASER-INDUCED CALCIUM FRACTURES | Research Development Foundation | ANJARIA, SHREYA PARAG | 3796 | Final Rejection | Dec 10, 2021 |
| 17616542 | FORMING OF DISINFECTANT SOLUTIONS | Control Chemicals (Pty) Ltd. | PATEL, PRANAV N | 1777 | Non-Final OA | Dec 03, 2021 |
| 17614638 | pH RESPONSIVE COMPOSITIONS AND USES THEREOF | The Board Of Regents Of The University Of Texas System | ROGERS, JAMES WILLIAM | 1618 | Final Rejection | Nov 29, 2021 |
| 17529492 | Systems and Methods for Recovering Lithium from Brines Field | Energy Exploration Technologies, Inc. | MENDEZ, ZULMARIAM | 1794 | Final Rejection | Nov 18, 2021 |
| 17607837 | MICRO-RNA SITE BLOCKING OLIGONUCLEOTIDES FOR THE TREATMENT OF EPILEPTIC ENCEPHALOPATHY AND NEURODEVELOPMENTAL DISORDERS | The Trustees of the University of Pennsylvania | SULLIVAN, STEPHANIE LAUREN | 1635 | Non-Final OA | Oct 29, 2021 |
| 17594651 | CRISPR/CAS9 GENE EDITING OF ATXN2 FOR THE TREATMENT OF SPINOCEREBELLAR ATAXIA TYPE 2 | The Children's Hospital of Philadelphia | BABIC, CHRISTOPHER M | 1633 | Non-Final OA | Oct 25, 2021 |
| 17604689 | COMPOUNDS WITH ANTI-TUMOR ACTIVITY AGAINST CANCER CELLS BEARING TYROSINE KINASE INHIBITOR RESISTANT EGFR MUTATIONS | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | MAHLUM, JONATHAN DAVIS | 1625 | Final Rejection | Oct 18, 2021 |
| 17604560 | COMPOUNDS AGAINST CANCER BEARING TYROSINE KINASE INHIBITOR RESISTANT EGFR MUTATIONS | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | ROBINSON, MIKHAIL O'DONNEL | 1627 | Non-Final OA | Oct 18, 2021 |
| 17604305 | COMPOUNDS AND METHODS FOR IMAGING IMMUNE ACTIVITY | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | MEJIAS, SAMANTHA LEE | 1618 | Final Rejection | Oct 15, 2021 |
| 17602392 | DUPLEX-SPECIFIC NUCLEASE DEPLETION FOR PURIFICATION OF NUCLEIC ACID SAMPLES | ZYMO RESEARCH CORPORATION | LAFAVE, ELIZABETH ROSE | 1684 | Non-Final OA | Oct 08, 2021 |
| 17600600 | COMBINATIONS OF TRANSCRIPTION INHIBITORS AND IMMUNE CHECKPOINT INHIBITORS FOR TREATMENT OF DISEASE | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | DONOGHUE, BRITTNEY ERIN | 1675 | Final Rejection | Sep 30, 2021 |
| 17598780 | NUCLEAR-DERIVED EXOSOMES AND METHODS OF USE THEREOF | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | SKOKO III, JOHN JOSEPH | 1643 | Final Rejection | Sep 27, 2021 |
| 17429182 | CODING RNA ADMINISTERED INTO THE SUPRACHOROIDAL SPACE IN THE TREATMENT OF OPHTHALMIC DISEASES | Curevac AG | FAY, ZOHREH ALEMZADEH | 1617 | Non-Final OA | Aug 06, 2021 |
| 17378954 | COMPOSITION FOR TREATING LUNG CANCER, PARTICULARLY OF NON-SMALL LUNG CANCERS (NSCLC) | Curevac AG | WILSON, MICHAEL C | 1638 | Final Rejection | Jul 19, 2021 |
| 17346563 | SYSTEMS AND METHODS FOR IMAGING AND MANIPULATING TISSUE | Research Development Foundation | HUH, VYNN V | 3792 | Non-Final OA | Jun 14, 2021 |
| 17295747 | METHODS OF OVERCOMING RESISTANCE TO IMMUNE CHECKPOINT INHIBITORS | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | STONEBRAKER, ALYSSA RAE | 1642 | Final Rejection | May 20, 2021 |
| 17289877 | T CELLS FROM LYMPHATIC FLUID FOR DIAGNOSTIC AND THERAPEUTIC USE | The Children's Hospital of Philadelphia | REDDIG, PETER J | 1646 | Non-Final OA | Apr 29, 2021 |
| 17235771 | BIOLOGICALLY ACTIVE DRY POWDER COMPOSITIONS AND METHOD OF THEIR MANUFACTURE AND USE | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | NGUYEN, JOHN P | 1619 | Non-Final OA | Apr 20, 2021 |
| 17286207 | NOVEL MEANS TO MODULATE NMDA RECEPTOR-MEDIATED TOXICITY | Fundamental Pharma GmbH | DABKOWSKI, ERINNE R | 1654 | Final Rejection | Apr 16, 2021 |
| 17276032 | COMBINATION CANCER THERAPIES | The Board Of Regents Of The University Of Oklahoma | ELENISTE, PIERRE PAUL | 1622 | Non-Final OA | Mar 12, 2021 |
| 17193511 | TREATMENT OF BRAIN CANCER WITH ONCOLYTIC ADENOVIRUS | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | GODDARD, LAURA B | 1642 | Non-Final OA | Mar 05, 2021 |
| 17272005 | SCALABLE TAGGING OF ENDOGENOUS GENES BY HOMOLOGY-INDEPENDENT INTRON TARGETING | The Children's Hospital of Philadelphia | REGA, KYLE THOMAS | 1636 | Non-Final OA | Feb 26, 2021 |
| 17180816 | MANIPULATING THE CIRCADIAN CLOCK TO INCREASE GENE EXPRESSION | VANDERBILT UNIVERSITY | SHARMA, SANTOSH | 1663 | Final Rejection | Feb 21, 2021 |
| 17265302 | ALTERNATIVE SPLICING REGULATION OF GENE EXPRESSION AND THERAPEUTIC METHODS | The Children's Hospital of Philadelphia | MCLEOD, AFRICA MHAIRIE | 1635 | Final Rejection | Feb 02, 2021 |
| 17155298 | SINGLE MOLECULE SEQUENCING IDENTIFICATION OF POST-TRANSLATIONAL MODIFICATIONS ON PROTEINS | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | ADAMS, MICHELLE | 1797 | Non-Final OA | Jan 22, 2021 |
| 17146912 | METHOD FOR REDUCING THE OCCURRENCE OF THROMBOSIS OR THROMBOEMBOLISM | Grifols Shared Services North America, Inc. | BEANE, RANDALL L | 1654 | Final Rejection | Jan 12, 2021 |
| 16972259 | DETECTION OF IMMUNE CHECKPOINT MOLECULES BY DEGLYCOSYLATION | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | RAMADAN, OMAR | 1678 | Non-Final OA | Dec 04, 2020 |
| 17054312 | PROXIMITY INDUCED SITE-SPECIFIC ANTIBODY CONJUGATION | William Marsh Rice University | VAN DRUFF, SYDNEY | 1643 | Non-Final OA | Nov 10, 2020 |
| 17047967 | MITOCHONDRIAL RNA IMPORT FOR TREATING MITOCHONDRIAL DISEASE | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | VYAS, KEYUR ANILKUMAR | 1637 | Non-Final OA | Oct 15, 2020 |
| 17045535 | PHARMACEUTICAL COMPOSITIONS FOR THE TRANSMUCOSAL DELIVERY OF THERAPEUTIC PEPTIDES AND PROTEINS | Cyprumed GmbH | MIKNIS, ZACHARY J | 1658 | Final Rejection | Oct 06, 2020 |
| 17045236 | NOVEL YELLOW FEVER NUCLEIC ACID MOLECULES FOR VACCINATION | Curevac AG | VYAS, KEYUR ANILKUMAR | 1637 | Non-Final OA | Oct 05, 2020 |
| 16964624 | SCREENING METHOD FOR ESTROGENIC AND ANTI-ESTROGENIC ACTIVITY | Bundesinstitut Für Risikobewertung | HUMPHRIES, NICHOLAS ADAM | 1631 | Final Rejection | Jul 24, 2020 |
| 16933773 | NUCLEIC ACID PURIFICATION | ZYMO RESEARCH CORPORATION | NGUYEN, QUANG | 1631 | Final Rejection | Jul 20, 2020 |
| 16757297 | METHODS AND COMPOSITIONS FOR THE PURIFICATION OF UNBIASED RNA | ZYMO RESEARCH CORPORATION | GREENE, CAROLYN LEE | 1681 | Final Rejection | Apr 17, 2020 |
| 16834504 | COMPACT FLUID WARMER | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | EKRAMI, YASAMIN | 3794 | Non-Final OA | Mar 30, 2020 |
| 16783376 | METHODS FOR CONDUCTING ASSAYS | Meso Scale Technologies, Llc. | TRAN, CHAU NGUYEN BICH | 1677 | Non-Final OA | Feb 06, 2020 |
| 16782772 | METHODS FOR DIFFERENTIATING PLURIPOTENT CELLS | Fujifilm Cellular Dynamics, Inc. | NOBLE, MARCIA STEPHENS | 1632 | Final Rejection | Feb 05, 2020 |
| 16348115 | AUTOMATED METHOD FOR RELEASE OF NUCLEIC ACIDS FROM MICROBIAL SAMPLES | ZYMO RESEARCH CORPORATION | MISHRA, DEEPA | 1657 | Non-Final OA | May 07, 2019 |
| 16098145 | IMPROVED DRUG FORMULATIONS | AustinPx, LLC | CRAIGO, WILLIAM A | 1615 | Final Rejection | Nov 01, 2018 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial